🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06808321
Enrolling by invitation Observational

Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients

NCT06808321 · tracked via the Priya Life Science Turkey tracker
Sponsor
The Society of Prevention and Awareness of Cardiovascular Diseases
Phase
Observational
Started
2025-03-01
Last updated
2025-09-09

Condition(s) studied

Chronic Coronary SyndromeHypertensionAngina Pectoris

Investigational drug(s) / intervention(s)

Benidipine Hydrochloride

Benidipine Hydrochloride: The safety and efficacy of a dihydropyridine calcium channel blocker for the treatment of high blood pressure and/or angina pectoris

Study summary

Evaluation of the clinical outcomes of Benidipine initiated by physician's preference in patients with hypertension and/or angina pectoris (chronic coronary syndrome) presenting to cardiology outpatient clinics in Turkey.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Patients with hypertension and/or angina pectoris on the background of chronic coronary syndrome who have been receiving Benidipine treatment for at least 1 month and will continue to receive Benidipine treatment * Male or female outpatients, 18-80 years of age * Patients with mild to moderate essential hypertension who have been receiving or will continue Benidipine treatment for at least 1 month * Outpatients with clinically stable angina pectoris and patients who have been receiving or will continue Benidipine treatment for at least 1 month * Those who signed the written informed consent form Exclusion Criteria: * Patients with secondary hypertension * Emergency hypertensive patients * Having to take other medications during the study that may affect blood pressure * Allergic to DHP calcium antagonists * Evidence of decompensated congestive heart failure, unstable angina or severe arrhythmia * Severe renal or hepatic dysfunction * Pregnant or lactating women * Participation in other clinical trials within 3 months prior to this study * Patients who did not sign the consent form of the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Antalya Kepez State Hospital Antalya Turkey (Türkiye)

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06808321 on ClinicalTrials.gov ↗ ← All trials in Turkey